Avanos Medical, Inc. (NYSE: AVNS) reported Q2 EPS of $0.17, $0.02 better than the analyst estimate of $0.15. Revenue for the quarter came in at $175 million versus the consensus estimate of $165.8 million.

GUIDANCE:

Avanos Medical, Inc. sees FY2025 EPS of $0.75-$0.95, versus the consensus of $0.85. Avanos Medical, Inc. sees FY2025 revenue of $665-685 million, versus the consensus of $672 million.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.